Key forces shaping the industry include rapid technology shifts—brushless‑motor designs, wireless torque monitoring, and longer‑life lithium‑ion batteries—that enhance surgical efficiency and reduce operative fatigue. Stringent regulatory pathways, especially FDA 510(k) clearances and EU MDR compliance, are driving manufacturers to invest in validation and post‑market surveillance, intensifying competitive pressure among incumbents such as Stryker, DePuy Synthes, and Zimmer Biomet. Supply‑chain dynamics are also evolving, with localized component sourcing in Asia‑Pacific accelerating cost advantages. Geographically, North America remains the largest market, anchored by high procedure volumes and robust healthcare spending, while the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by expanding orthopedic surgery capacity in China and India. These trends collectively signal a sustained industry expansion and present strategic entry points for innovators and investors.